<?xml version="1.0" encoding="UTF-8"?>
<p id="p0040">Moreover, the protein-coding genes of SARS-CoV-2 have 79.5% and 51% sequence similarity to SARS-CoV and MERS-CoV, respectively. The SARS-CoV-2 virus employs the Angiotensin-Converting Enzyme 2 (ACE2) receptor for cellular entry, similar to SARS-CoV 
 <xref rid="b0015" ref-type="bibr">[3]</xref>, 
 <xref rid="b0070" ref-type="bibr">[14]</xref>. Therefore, previous treatments that were used to control the SARS-CoV and MERS-CoV epidemics, might also be effective in SARS-CoV-2.
</p>
